What is the ICD 10 code and treatment for acute simple cystitis in a female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Code and Treatment for Acute Simple Cystitis in Females

ICD-10 Code

The ICD-10 code for acute simple (uncomplicated) cystitis in females is N30.00 (acute cystitis without hematuria) or N30.01 (acute cystitis with hematuria). 1

First-Line Treatment Recommendations

For acute uncomplicated cystitis in women, nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days is the preferred first-line treatment due to minimal resistance patterns and excellent efficacy. 1, 2

Primary Treatment Options (in order of preference):

  • Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days - This is the most strongly recommended first-line agent with minimal collateral damage and resistance rates 1, 2

  • Fosfomycin trometamol 3 grams as a single oral dose - Highly convenient single-dose therapy, though slightly lower efficacy than multi-day regimens 1, 3

    • FDA-approved specifically for uncomplicated UTIs in women 3
    • Should be avoided if early pyelonephritis is suspected 1
  • Trimethoprim-sulfamethoxazole 160/800 mg (one double-strength tablet) twice daily for 3 days - Only use if local E. coli resistance rates are <20% or if the organism is known to be susceptible 1

    • Avoid if this agent was used for UTI in the previous 3 months 1
  • Pivmecillinam 400 mg three times daily for 3-5 days - Good option where available (primarily Europe), though with slightly lower efficacy 1, 2

Alternative Options When First-Line Agents Cannot Be Used

  • Cephalosporins (e.g., cefadroxil 500 mg twice daily for 3 days) - Use only if local E. coli resistance is <20% 1, 2

  • Fluoroquinolones (ciprofloxacin, levofloxacin) - Reserve for more serious infections due to collateral damage concerns (C. difficile, tendinopathy) and increasing resistance 1, 2, 4

    • Should NOT be first-line despite high efficacy 2

Diagnostic Approach

Diagnosis can be made clinically based on acute-onset dysuria plus urinary frequency/urgency in the absence of vaginal discharge or irritation. 1, 5

When to obtain urine culture:

  • Suspected pyelonephritis (fever, flank pain) 1
  • Symptoms not resolving or recurring within 4 weeks after treatment 1
  • Atypical symptoms 1
  • Pregnancy 1
  • Recurrent UTIs (≥3 UTIs/year or 2 UTIs in 6 months) 1

When urine culture is NOT needed:

  • Typical symptoms in otherwise healthy premenopausal women 1, 5
  • Routine post-treatment follow-up in asymptomatic patients 1

Important Clinical Considerations

Avoid β-lactams (including amoxicillin/ampicillin) for empirical treatment due to inferior efficacy and high resistance rates. 2

For women with mild to moderate symptoms, symptomatic therapy with NSAIDs (e.g., ibuprofen) may be considered as an alternative to antimicrobials after shared decision-making. 1

Treatment Failure Management

If symptoms persist or recur within 2 weeks, obtain urine culture and assume the organism is not susceptible to the initial agent. 1

  • Retreat with a 7-day regimen using a different antimicrobial class 1
  • Do not use the same agent that failed initially 1

Key Pitfalls to Avoid

  • Do not routinely perform cystoscopy or imaging in women <40 years with recurrent UTI and no risk factors 1
  • Do not use amoxicillin or ampicillin empirically - high resistance rates make these ineffective 2
  • Avoid nitrofurantoin if pyelonephritis is suspected - inadequate tissue penetration 1
  • Consider local antibiogram patterns - resistance varies by region and should guide empirical choices 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Alternatives to Cephalexin for Uncomplicated Cystitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of acute uncomplicated cystitis.

American family physician, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.